Literature DB >> 2155676

Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor.

R J Ford1, A Goodacre, I Ramirez, S R Mehta, F Cabanillas.   

Abstract

B-cell non-Hodgkin's lymphomas (NHL-B) have been difficult to establish in long-term cell culture using standard techniques. We report the establishment of five representative cell lines from high grade NHL-B using B-cell growth factor (BCGF). The five NHL-B cell lines display the morphologic, immunophenotypic, genotypic, and biologic characteristics of the lymphoma cells present in the original diagnostic specimen. The cell lines showed at least a sevenfold dose-dependent increase in proliferation in vitro over background in the presence of BCGF. Other putative B-cell growth-stimulating cytokines showed no significant proliferative activity or were inhibitory in some cases. NHL-B cell lines secreted growth factor(s) into culture supernatants that mediated at least a fivefold dose-dependent increase in cell proliferation in autochthonous lymphoma cells and a 10-fold or greater stimulation in growth factor-dependent normal B cell lines in vitro. The cell lines show monoclonal rearrangements of IgH genes and nonrandom chromosomal abnormalities characteristic of NHL-B, while the expression of Epstein-Barr virus associated antigen (EBNA-I) is present in two of the five cell lines. The studies show that lineage-specific growth factors may be used to establish neoplastic B cell lines in vitro, which are important experimental systems for cellular and molecular studies in the NHL-B.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155676

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.

Authors:  Lingchen Fu; Yen-Chiu Lin-Lee; Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

2.  Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Yen-Chiu Lin-Lee; Richard J Ford
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

3.  Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS.

Authors:  R C Bohannon; L A Donehower; R J Ford
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.

Authors:  Lan V Pham; Lingchen Fu; Archito T Tamayo; Carlos Bueso-Ramos; Elias Drakos; Francisco Vega; L Jeffrey Medeiros; Richard J Ford
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

5.  An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.

Authors:  Lan V Pham; Archito T Tamayo; Changping Li; Carlos Bueso-Ramos; Richard J Ford
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

6.  Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.

Authors:  Lingchen Fu; Yen-Chiu Lin-Lee; Lan V Pham; Archito Tamayo; Linda Yoshimura; Richard J Ford
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

7.  Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Authors:  Hai-Jun Zhou; Lan V Pham; Archito T Tamayo; Yen-Chiu Lin-Lee; Lingchen Fu; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2007-06-13       Impact factor: 22.113

8.  B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

Authors:  Li Li; Jun Zhang; Juan Chen; Zijun Y Xu-Monette; Yi Miao; Min Xiao; Ken H Young; Sa Wang; L Jeffrey Medeiros; Michael Wang; Richard J Ford; Lan V Pham
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

9.  Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Authors:  E Drakos; R R Singh; G Z Rassidakis; E Schlette; J Li; F X Claret; R J Ford; F Vega; L J Medeiros
Journal:  Leukemia       Date:  2011-03-11       Impact factor: 11.528

10.  Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.

Authors:  Changping Li; Michael A Thompson; Archito T Tamayo; Zhuang Zuo; John Lee; Francisco Vega; Richard J Ford; Lan V Pham
Journal:  Oncotarget       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.